← Back to Search

Multi-level Intervention for Childhood Cancer Survivorship Care Adherence (BRIDGES Trial)

Q: Are there still opportunities to join this research endeavor?

Affirmative. According to clinicaltrials.gov, this research study is currently seeking participants who meet the inclusion criteria and are willing to volunteer. It was first posted on January 1st 2021 with the last update being February 27th of that same year. A total of 240 individuals need to be selected from 4 different medical sites for participation in this trial.

Q: In which areas is this research program accessible?

In addition to the aforementioned locations, this clinical trial is also enrolling patients at Children's Hospital <a href="https://www.withpower.com/clinical-trials/colorado">Colorado</a> in Denver, Hackensack University Medical Center in <a href="https://www.withpower.com/clinical-trials/new-jersey">New jersey</a> and University of <a href="https://www.withpower.com/clinical-trials/north-carolina">North carolina</a> Children's Hospital located in Chapel Hill.

Q: How many participants are engaging in this investigation?

With 240 candidates needed to adequately conduct this trial, patients residing near Children's Hospital <a href="https://www.withpower.com/clinical-trials/colorado">Colorado</a> in Denver and Hackensack University Medical Center in <a href="https://www.withpower.com/clinical-trials/new-jersey">New jersey</a> are particularly encouraged to apply. Eligibility for enrollment is contingent on meeting the predetermined inclusion criteria.

N/A

Recruiting

Led By Nina Kadan-Lottick, MD, MSPH

Research Sponsored by Georgetown University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with any cancer at age <21 years

Treated with chemotherapy and/or radiation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2-years post-randomization

Awards & highlights

BRIDGES Trial Summary

This trial tests an innovative multi-level intervention to help childhood cancer survivors get needed care & reduce disparities. Goal: high adherence to recommended surveillance, better patient & physician knowledge & self-efficacy.

Who is the study for?

This trial is for childhood cancer survivors who are 2-4 years post-treatment, cancer-free with a life expectancy of over 2 years, and have not attended a specialty survivorship clinic. Participants must be English or Spanish speakers (including guardians if under 18) and treated at one of the four specified sites.Check my eligibility

What is being tested?

The study tests an intervention to improve adherence to survivorship care. It includes telehealth education, tailored online programs, phone communication between the cancer center and primary care, and an in-person primary care visit.See study design

What are the potential side effects?

Since this trial focuses on educational interventions rather than medications or medical procedures, there are no direct side effects associated with traditional clinical treatments.

BRIDGES Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was diagnosed with cancer before turning 21.

Select...

I have undergone chemotherapy or radiation treatment.

Select...

I am cancer-free and expected to live 2 more years or longer.

BRIDGES Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years post-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years post-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years post-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient completion of guideline-recommended surveillance tests for late effects of therapy

Secondary outcome measures

PCP Knowledge and Self-Efficacy

Patient Activation

Patient Healthcare Self-Efficacy

+3 more

Other outcome measures

Post-intervention qualitative interviews of participants and PCPs

BRIDGES Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Multi-level Intervention of shared model of survivorship careExperimental Treatment1 Intervention

Patient survivorship education via telehealth with the cancer center Ongoing patient-tailored education program by MyChart within the EHR patient portal Structured interactive phone communication between the research RN at the cancer center and community PCP clinic In-person visit with the PCP clinic for survivorship care.

Group II: "Gold standard" cancer center-based survivorship clinicActive Control1 Intervention

In-person visit at specialty survivorship clinic

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor

343 Previous Clinical Trials

136,262 Total Patients Enrolled

University of North Carolina, Chapel HillOTHER

1,508 Previous Clinical Trials

4,190,794 Total Patients Enrolled

University of Colorado, DenverOTHER

1,736 Previous Clinical Trials

2,148,955 Total Patients Enrolled

Media Library

Multi-level Intervention of shared model of survivorship care Clinical Trial Eligibility Overview. Trial Name: NCT05448560 — N/A

Survivorship Research Study Groups: Multi-level Intervention of shared model of survivorship care, "Gold standard" cancer center-based survivorship clinic

Survivorship Clinical Trial 2023: Multi-level Intervention of shared model of survivorship care Highlights & Side Effects. Trial Name: NCT05448560 — N/A

Multi-level Intervention of shared model of survivorship care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05448560 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to join this research endeavor?

"Affirmative. According to clinicaltrials.gov, this research study is currently seeking participants who meet the inclusion criteria and are willing to volunteer. It was first posted on January 1st 2021 with the last update being February 27th of that same year. A total of 240 individuals need to be selected from 4 different medical sites for participation in this trial."

Answered by AI

In which areas is this research program accessible?

"In addition to the aforementioned locations, this clinical trial is also enrolling patients at Children's Hospital Colorado in Denver, Hackensack University Medical Center in New jersey and University of North carolina Children's Hospital located in Chapel Hill."

Answered by AI

How many participants are engaging in this investigation?

"With 240 candidates needed to adequately conduct this trial, patients residing near Children's Hospital Colorado in Denver and Hackensack University Medical Center in New jersey are particularly encouraged to apply. Eligibility for enrollment is contingent on meeting the predetermined inclusion criteria."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship

2023. "A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05448560.